Reversal of malignant ADAR1 splice isoform switching with Rebecsinib is a research paper published in Cell stem cell (2023). On theSindex it has a DataRank of 0. It has been cited 69 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK
Grant: R01DK114468-01
NCI
Grant: R01CA205944
NCI
Grant: 2P30CA023100-28
NCATS
Grant: UL1TR001442
National Aeronautics and Space Administration
Grant: NRA-NNJ13ZBG001N
CIRM
Grant: TRAN1-10540
NIDDK NIH HHS
Grant: R01 DK114468
NCI NIH HHS
Grant: P30 CA023100
National Institutes of Health
Leukemia & Lymphoma Society
MPN Research Foundation
MeSH Terms
Keywords